RecruitingNCT02879071

Long Term Follow-up After Embolization of Brain Arteriovenous Malformations

Sponsor

Fondation Ophtalmologique Adolphe de Rothschild

Enrollment

1,000 participants

Start Date

Nov 26, 2015

Study Type

OBSERVATIONAL

Conditions

Arteriovenous Malformations

Summary

The time-frame and the follow-up elements after embolization of brain arteriovenous malformations are not standardized. Therefore, few reliable follow-up data are available for these patients. This study aims at collecting standardized long term data for these patients.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is following patients long-term after they received endovascular embolisation to treat a brain arteriovenous malformation (AVM) — an abnormal tangle of blood vessels in the brain that can rupture and cause bleeding. Researchers want to understand how patients do years after treatment and whether the AVM stays sealed. You may be eligible if: - You have a brain arteriovenous malformation (AVM) - You have had embolisation treatment - You are over 18 years old You may NOT be eligible if: - There are no stated exclusion criteria for this study Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(1)

Fondation Ophtalmologique Adolphe de Rothschild

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT02879071

Related Trials

Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous Malformations

NCT0204232613 locations

A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations

NCT059831592 locations